Date Name Title Filing Type Shares Traded Price Total Held
Jan 05, 2005
VP, Regulatory Development
VP, Regulatory Development Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 13,650 -- --
Dec 15, 2004
VP, Regulatory Development
VP, Regulatory Development Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,399 -- 19,829
Dec 15, 2004
VP, Regulatory Development
VP, Regulatory Development Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 11,188 -- 11,188
Dec 15, 2004
VP, Regulatory Development
VP, Regulatory Development Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 18,812 -- 18,812
Dec 15, 2003
VP, Regulatory Development
VP, Regulatory Development Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 3,893 -- 11,024
Dec 15, 2003
VP, Regulatory Development
VP, Regulatory Development Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 -- 5,000
Dec 15, 2003
VP, Regulatory Development
VP, Regulatory Development Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 -- 15,000
Dec 18, 2008
VP, Regul Devel & Med Safety
VP, Regul Devel & Med Safety Form 4 Other acquisition or disposition -- -- 3,127
Dec 18, 2008
VP, Regul Devel & Med Safety
VP, Regul Devel & Med Safety Form 4 Other acquisition or disposition -- -- 8,106
Dec 17, 2008
VP, Regul Devel & Med Safety
VP, Regul Devel & Med Safety Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,952 -- 5,952

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.